Agios Pharmaceuticals(AGIO) - 2020 Q4 - Annual Report
Agios Pharmaceuticals(AGIO)2021-02-25 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36014 | --- | --- | |------------------------------------------------------------------------------------|-----------------------------------| | AGIOS ...